Skip to main content
logo
Innovita Biological Technology Co., Ltd. (SHA:688253)
China flag China · Delayed Price · Currency is CNY
30.52
-0.22 (-0.72%)
At close: Jul 11, 2025, 2:57 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Respiratory Tract Series - Non-COVID-19 Products
405.49M
Log In
Log In
Log In
Log In
Respiratory Tract Series - Non-COVID-19 Products Growth
-
Log In
Log In
Log In
Log In
Respiratory Tract Series - COVID-19 Products
58.21M
Log In
Log In
Log In
Log In
Respiratory Tract Series - COVID-19 Products Growth
-
Log In
Log In
Log In
Log In
Other Series
9.64M
Log In
Log In
Log In
Log In
Other Series Growth
-35.97%
Log In
Log In
Log In
Log In
Eugenics and Nurturing Series
4.14M
Log In
Log In
Log In
Log In
Eugenics and Nurturing Series Growth
8.31%
Log In
Log In
Log In
Log In
Point-of-care Testing Diagnostic Instrument
530.97K
Log In
Log In
Log In
Log In
Point-of-care Testing Diagnostic Instrument Growth
200.00%
Log In
Log In
Log In
Log In
Respiratory Tract Series
-
Log In
Log In
Log In
Log In
In Vitro Diagnostic Testing Equipment
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
China
464.96M
Log In
Log In
Log In
Log In
China Growth
10.45%
Log In
Log In
Log In
Log In
Overseas (including Hong Kong, Macau and Taiwan)
13.06M
Log In
Log In
Log In
Log In
Overseas (including Hong Kong, Macau and Taiwan) Growth
-49.12%
Log In
Log In
Log In
Log In